SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera (HBAR) is seeing a surge in community engagement and price action driven by speculation that it may follow the recent institutional adoption seen in other major ledger networks. Investors are actively discussing the potential impact of pending regulatory clarity and the long-term utility of Hedera's enterprise infrastructure on the token's valuation.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining Corp is trending due to significant community focus on its strategic positioning in the copper market, alongside the upcoming North American IPO of its dedicated regional assets. Investors are actively debating the company's long-term valuation potential as a dual-metal play, while weighing these catalysts against prevailing macro concerns over inflationary pressures and geopolitical instability.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Investors are flocking to SCHD as a defensive anchor for their portfolios, drawn to its focus on quality dividend growth and financial stability during periods of market turbulence. Community discussion is heavily focused on long-term wealth building, with many members viewing the fund as a core "hold-forever" asset that provides reliable cash flow amidst volatility in tech and growth-oriented sectors.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is generating significant conversation as investors focus on its monthly dividend payouts and the strategy of using covered calls to generate income from large-cap technology stocks. Many in the community are actively discussing the balance between dividend income and capital appreciation, with ongoing debates about how the fund compares to other popular income-focused ETFs during periods of market volatility.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending as investors focus on institutional accumulation from major firms like Morgan Stanley and BlackRock, alongside significant short interest that has sparked speculation about a potential squeeze. Market participants are closely watching the upcoming earnings release and the potential impact of founder Thomas Siebel's return as CEO on the company's financial turnaround and sales execution.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) remains a focal point for traders navigating extreme volatility as they weigh the impact of shifting U.S. interest rate expectations and geopolitical tensions on silver's price. The community is actively debating whether current pullbacks represent a buying opportunity for a supply-constrained metal or a signal to exit leveraged positions before further potential downside.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

Investors are flocking to QQQI for its high-yield monthly income strategy, which uses covered calls on Nasdaq-100 exposure to generate significant cash flow. While the community is actively debating the trade-offs between income generation and capped growth, many are using the ETF as a core component of their long-term passive income portfolios.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibb is trending as investors react to solid quarterly earnings beats, upwardly revised full-year guidance, and a pipeline bolstered by ongoing collaborations and successful trial readouts. The community is actively discussing the company's potential for near-term growth, the impact of its strategic AI partnerships, and the competitive landscape surrounding upcoming product launches.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is generating significant investor attention as the community weighs a potential, though speculative, acquisition by a major tech player against its current depressed valuation and high short interest. While bulls highlight improving profitability, share repurchases, and strategic partnerships, skeptics remain focused on competitive pressures from autonomous vehicle initiatives and stagnant long-term price action.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is trending as investors debate whether the current price levels offer a generational accumulation opportunity or reflect the project's long-term stagnation. While some community members highlight technical milestones and whale accumulation as signs of a pending breakout, others express frustration over poor price performance and leadership, fueling an intense divide between patient holders and those calling for an exit.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Moderna shares are trending as investors digest the company's aggressive pivot toward a diversified oncology and autoimmune pipeline following recent Science Day announcements. The market is actively debating the stock's long-term growth potential and high short interest, with many traders closely tracking institutional accumulation and upcoming regulatory catalysts for its flu vaccine platform.

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

Moderna's Q2 revenue tops estimates, but shares fall after its phase III norovirus vaccine study misses early success criteria.

Moderna Burns Cash, Suffers Fresh Vaccine Setback

Moderna (MRNA) Q2 Earnings: Beat estimates with $145M in sales and a $1.97 EPS loss. Reaffirms 2026 sales guidance.read more...

Stocks making the biggest moves premarket: Replimune, Chevron, Apple, Amazon, Moderna & more

These are the stocks posting the largest moves premarket...

Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates

Moderna (MRNA) delivered earnings and revenue surprises of 0.00% and +14.49%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Moderna, Inc Q2 Loss Decreases

(RTTNews) - Moderna, Inc (MRNA) released Loss for second quarter of -$782 million...

Moderna Q2 26 Earnings Conference Call At 8:00 AM ET

(RTTNews) - Moderna, Inc (MRNA) will host a conference call at 8:00 AM ET on July 31, 2026, to discuss Q2 26 earnings results...

Moderna Q2 Earnings Loom: Buy or Sell the Stock Ahead of Results?

MRNA is likely to face a key Q2 test as investors await results, FDA updates on mRNA-1010 and commercialization plans that could shape its post-COVID growth.

Moderna Stock Has Doubled in 2026, But Wall Street Still Isn't Convinced

Moderna Stock Has Doubled in 2026, But Wall Street Still Isn't Convinced...

Moderna (MRNA) Laps the Stock Market: Here's Why

In the most recent trading session, Moderna (MRNA) closed at $55.63, indicating a +2.89% shift from the previous trading day.

Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?

Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

$MRNA Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$1.97 up 7.51% YoY
• Reported revenue of $145M up 2.11% YoY
• Moderna targets up to 10% revenue growth for 2026, with an improved GAAP operating expense outlook of approximately $2.9 billion and a projected year-end cash balance of $4.7 to $5.2 billion.

Stocktwits

Moderna Inc

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$1.97 up 7.51% YoY
• Reported revenue of $145M up 2.11% YoY
• Moderna targets up to 10% revenue growth for 2026, with an improved GAAP operating expense outlook of approximately $2.9 billion and a projected year-end cash balance of $4.7 to $5.2 billion.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions

Equity

Neutral Sentiment

$CMPS

$SOUN

$MRNA

$LCID

Compass Pathways ($CMPS), SoundHoundAI ($SOUN), Moderna ($MRNA), and Lucid Group ($LCID) are four of the most searched and talked-about stocks among retail investors this morning. Which are you most bullish? Drop your reasoning in the comments.

Which of these trending stocks are you most bullish on for the next 5 years - $CMPS, $SOUN, $MRNA, or $LCID?

Feed

News

Sentiment

Earnings

Fundamentals

Info

MRNAModerna Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest MRNA News